摘要
丙型肝炎病毒HCV是慢性肝炎、肝硬化以及肝细胞癌的主要原因。大量的研究指出许多能够在肝生理学上呈阳性结果的微型RNAs能够调节HCV感染或者被其调节。许多研究显示HCV利用宿主miRNAs 以及通过与HCV的RNA基因作用或者间接地控制于病毒复制相关的宿主通路从而调节HCV复制的表达,最终诱导与HCV相关的肝性疾病如肝纤维化、肝硬化或HCC。近期,在人类血清和血浆中检测到的细胞外miRNAs(循环miRNAs)被认为是病理条件下候选生物标记物,由于其性质非常稳定以及治疗的非侵入性。因为这些循环miRNAs, 大量的努力投入研究与HCV感染以及肝疾病相关的循环miRNAs模式的变化。本文综述了miRNAs在HCV相关的肝性疾病的发生和发展中的特点,并讨论了越来越多的那些能够区分与HCV感染和肝疾病相关的循环miRNA模式的证据。本文也强调了在HCV感染和相关疾病的诊断和预测中基于miRNA治疗形态和非侵入性生物标记物的进展。
关键词: 生物标记物,循环miRNAs
图形摘要
Current Drug Targets
Title:The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection
Volume: 18 Issue: 7
关键词: 生物标记物,循环miRNAs
摘要: Hepatitis C virus (HCV) is a worldwide major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Accumulating evidence indicates that a number of microRNAs (miRNAs), which are able to exert an effect on liver biology and pathology, can regulate or be regulated by HCV infection. Many studies demonstrate that HCV utilizes host miRNAs and modulates expression of miRNAs in infected hepatocytes for its infection and propagation. In turn, host miRNAs can directly regulate HCV replication through interaction with the HCV RNA genome or by indirectly controlling the host pathways associated with the virus replication, which eventually induce HCV-related liver diseases such as liver fibrosis, hepatic cirrhosis, or HCC. Recently, extracellular miRNAs (circulating miRNAs) detected in human serum and plasma are proposed as biomarker candidates for pathological conditions due to their remarkably stable nature and the non-invasiveness of their detection. Since these circulating miRNAs exhibit consistent levels between healthy individuals but significantly changed profiles in disease conditions, considerable effort has been employed to investigate the alteration in the circulating miRNA pattern that is related with HCV infection and associated liver diseases. In this review, we summarize the features of miRNAs critical for HCVassociated liver disease initiation and progress, and discuss growing evidence that distinctive circulating miRNA patterns are related with HCV infection and associated liver diseases. These will shed light on the development of miRNA-based therapeutic modalities and non-invasive biomarkers for the diagnosis and prognosis of HCV infection and associated diseases.
Export Options
About this article
Cite this article as:
The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection, Current Drug Targets 2017; 18 (7) . https://dx.doi.org/10.2174/1389450117666160401125213
DOI https://dx.doi.org/10.2174/1389450117666160401125213 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combating P-glycoprotein-Mediated Multidrug Resistance Using Therapeutic Nanoparticles
Current Pharmaceutical Design Targeted – Therapy and Imaging Response: A New Paradigm For Clinical Evaluation?
Reviews on Recent Clinical Trials The Role of the Transcription Factor E2F1 in Hepatocellular Carcinoma
Current Drug Delivery Recent Progress in the Development of Small Molecule c-Met Inhibitors
Current Topics in Medicinal Chemistry Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Patient Radiation Doses in Interventional Cardiology Procedures
Current Cardiology Reviews RNA Interference as Therapeutics for Hepatocellular Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Protein Engineering: A New Frontier for Biological Therapeutics
Current Drug Metabolism Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics
Current Pharmaceutical Biotechnology Phytoconstituents of <i>Lantana camara</i> L.: Rekindling Hope in the Cancer Treatment
Current Bioactive Compounds Promising Anti-Fibrotic Approaches for Future Treatment of Systemic Sclerosis
Current Rheumatology Reviews Withdrawal Notice: Recent Developments in Anti-Cancer Activity of Compounds Containing the Thioether Group
Anti-Cancer Agents in Medicinal Chemistry Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature
Reviews on Recent Clinical Trials Decreasing Systemic Toxicity Via Transdermal Delivery of Anticancer Drugs
Current Drug Metabolism Somatostatin and Octreotide on the Treatment of Acute Pancreatitis - Basic and Clinical Studies for Three Decades
Current Pharmaceutical Design Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells
Current Immunology Reviews (Discontinued) Cdc25A Protein Phosphatase: A Therapeutic Target for Liver Cancer Therapies
Anti-Cancer Agents in Medicinal Chemistry